Page last updated: 2024-10-31

mianserin and Alice in Wonderland Syndrome

mianserin has been researched along with Alice in Wonderland Syndrome in 1 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Alice in Wonderland Syndrome: Neurological condition characterized by disturbances in VISUAL PERCEPTION, most often of BODY SCHEMA, TIME PERCEPTION and HALLUCINATIONS. It is associated with MIGRAINE, infections (e.g., INFECTIOUS MONONUCLEOSIS), FEVER, EPILEPSY, and other neurological and psychiatric disorders.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yrondi, A1
Schmitt, L1
Arbus, C1

Other Studies

1 other study available for mianserin and Alice in Wonderland Syndrome

ArticleYear
["Alice in wonderland syndrome", a precursor of depressive disorder with melancholic characteristics].
    L'Encephale, 2017, Volume: 43, Issue:5

    Topics: Aged; Alice in Wonderland Syndrome; Antidepressive Agents, Second-Generation; Antimanic Agents; Comb

2017